local_hospital

Przychodnia Alergologiczno-Pulmonologiczna Alergopneuma Sp. z o.o.

Address
Ul. Kolejowa 3, 21-047 Swidnik, Poland

Przychodnia Alergologiczno-Pulmonologiczna Alergopneuma Sp. z o.o.

This specialized allergology and pulmonology clinic focuses on advanced respiratory disease management and participates in cutting-edge clinical research. The center demonstrates expertise in chronic respiratory conditions, with particular emphasis on structural airway diseases and long-term therapeutic interventions.

  • Bronchiectasis research and long-term safety monitoring
  • Novel pharmacological treatments for chronic respiratory conditions
  • Extended follow-up studies for respiratory disease management

The clinic's involvement in multi-phase clinical trials, including continuation studies for bronchiectasis patients, highlights their commitment to evaluating long-term safety profiles and treatment outcomes. Their participation in the Clairleaf TM study demonstrates capability in monitoring treatment-emergent adverse events and providing comprehensive care for patients with complex airway pathologies.

Site Overview

assignment
1
connected trial
corporate_fare
3
sponsors
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
3
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
1
Outperforms 1% of sites
public
Therapeutic diversity
1areas
Outperforms 1% of sites
groups
Sponsor diversity
3sponsors
Outperforms 58% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Przychodnia Alergologiczno-Pulmonologiczna Alergopneuma Sp. z o.o.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis: A Randomized, Double-Blind, Parallel Group, Roll-Over StudyBoehringer Ingelheim Espana S.A., Boehringer Ingelheim International GmbH, Boehringer Ingelheim RCV GmbH & Co. KGPhase IINot RecruitingSep 2023

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Bi 12915831Unknown2023-09-052023-09-05

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.